Facebook Linkedin Twitter
Inside Precision Medicine First Positive Data of In Vivo CRISPR-Based Genome Editing in Humans Reported

Regeneron

CRISPR technology
News & Features

First Positive Data of In Vivo CRISPR-Based Genome Editing in Humans Reported

0
World map, illustration
Molecular Dx

Twist Develops Diverse Genotyping Option with Regeneron Genetics Center

0
Antibodies responding to covid-19 coronavirus, illustration
Coronavirus

Antibody Candidates to Treat COVID-19 from Lilly, Regeneron Show Positive Phase III Data

0
Doctor hold a vial of monoclonal antibodies, a new treatment for coronavirus Covid-19
Coronavirus

Regeneron’s COVID-19 Antibody Cocktail Trial Releases Encouraging Early Data

0
Antibodies responding to COVID-19 coronavirus, illustration
Coronavirus

Regeneron’s COVID-19 Antibody “Cocktail” Granted Emergency Use Authorization by FDA

0
Coronavirus structure, illustration
Coronavirus

Regeneron’s Two-Antibody COVID-19 Treatment “Cocktail” Reduces Viral Load

0
Antibodies responding to covid-19 coronavirus, illustration
Coronavirus

Regeneron’s Antibody Cocktail Effectively Treats and Prevents COVID-19 in Animal Studies

0
Researching vaccine to novel coronavirus 2019-nCoV. Close-up shot of a scientist preparing glass slide.
Coronavirus

Regeneron, Moderna Return Encouraging Early Data on COVID-19 Clinical Trials

0
Coronavirus Covid-19 Vaccine
Coronavirus

Novavax Secures $1.6B in Funding for COVID-19 Vaccine Efforts

0
genomic medicine
Informatics

Regeneron, Colorado Center for Personalized Medicine Enter Broad Genetics Research Collaboration

0
123Page 2 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine